Research News and Research

RSS

Scripps Health offers genetic testing to patients with Hepatitis C

Scripps Health is one of the first health systems in the United States to offer genetic testing as part of its care for hepatitis C patients planning to undergo drug treatment.

28 Feb 2011

Acute viral infection does not appear to cause exacerbation of IPF

Acute viral infection does not appear to be a primary cause of acute exacerbation of idiopathic pulmonary fibrosis, a progressive, deadly disease resulting in thickening and scarring of the lungs, according to a study conducted by researchers from the U.S., Korea and Japan.

28 Feb 2011

Researchers identify gene behind self-healing skin cancer

Cancer Research UK scientists have discovered the gene behind a rare skin cancer which grows rapidly for a few weeks before healing spontaneously, according to research published in Nature Genetics.

28 Feb 2011

Johns Hopkins students to provide hands-on help to communities in need on spring break trip

In the coming months, college students across the U.S. will make their annual southern pilgrimage for fun in the sun. At the Johns Hopkins School of Nursing, however, 16 students have a different agenda for a southern spring break: providing hands-on help to communities in need.

27 Feb 2011

Scientists discover killer protein that protects against development of cancer

Scientists at Trinity College Dublin have made an important discovery concerning how fledgling cancer cells self-destruct, which has the potential of impacting on future cancer therapies.

27 Feb 2011

New findings disclose mechanisms that control Rb2/p130 gene expression in lung cancer cells

Despite innumerable studies on lung cancer, many aspects of the disease have yet to be understood, including the role played by the retinoblastoma-related protein Rb2/p130 in the evolution of the disease.

27 Feb 2011

Encouraging preliminary results from Synta's ganetespib Phase 2 trial against non-small cell lung cancer

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that encouraging preliminary results of a Phase 2 trial of ganetespib as a single agent in non-small cell lung cancer were presented at the International Association for the Study of Lung Cancer 11th Annual Targeted Therapies for the Treatment of Lung Cancer Meeting.

27 Feb 2011

Takeda receives FDA approval for EDARBI to treat hypertension in adults

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration approved EDARBI for the treatment of hypertension, or high blood pressure, in adults.

27 Feb 2011

New study: Immune molecules can regulate synaptic connections in brain

The number of connections between nerve cells in the brain can be regulated by an immune system molecule, according to a new study from UC Davis. The research, published Feb. 27 in the journal Nature Neuroscience, reveals a potential link between immunity, infectious disease and conditions such as schizophrenia or autism.

27 Feb 2011

Lyme’s disease and chronic fatigue syndrome biomarkers found

A new study shows that spinal fluid can be used to detect proteins that help distinguish patients with Lyme disease from those with chronic fatigue syndrome.

27 Feb 2011

Well-being in adolescence linked to life satisfaction in adulthood

Being a 'happy' teenager is linked to increased well-being in adulthood, new research finds.

25 Feb 2011

Less-toxic combination of immune-based drug and chemotherapy drug produce long-term remissions in CLL

New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients. And it does so without increasing the risk of later therapy-related myelodysplastic syndrome and acute myeloid leukemia, which can often occur with a three-drug combination used to treat these patients.

25 Feb 2011

Research Roundup: Health costs at life's end; Assessing hospital quality; Surgeons' burnout; Per capita Medicaid spending

Annals of Internal Medicine: Determinants Of Medical Expenditures In The Last 6 Months Of Life - Identifying factors about patients in the final six months of life that affect the level of care needed "may reveal opportunities for patient-centered interventions to predict and to reduce medical costs," write the authors, while noting that the study had "a large proportion of unexplained variation."

25 Feb 2011

State News: Ga. Senate oks insurance mandates bill; Va. Assembly says abortion clinics should be regulated as hospitals

State agencies, county prosecutors, insurance companies, and health care employers and associations are mandatory reporters — they're required to report potentially dangerous and unprofessional doctors to medical regulators, who can bar the doctors from practicing and keep patients out of harm's way. But the mandatory reporters sound few alarms, and when they do, regulators rarely take action, the Tribune found.

25 Feb 2011

Viewpoints: WSJ on Medicare Advantage, Texas Gov. Perry on 'Fed inroads,' Med students' health policy ignorance

The White House has apparently decided that it won't enforce the unpopular parts of its health-care plan until after the 2012 election. The latest evidence is its decision not to slash Medicare Advantage, the program that Democrats hate because it lets seniors choose private insurance options. ... Would this be the same Medicare Advantage that candidate Barack Obama vowed to eliminate, saying in 2007 that "We shouldn't be rewarding the insurance industry for deceiving and defrauding our seniors"? (2/25).

25 Feb 2011

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

Medtronic, Inc. today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery (FESS).

25 Feb 2011

CIGNA's integrated disability and medical programs reduce workplace absence

Employees who have both disability and medical coverage from CIGNA, and who also suffer a short-term disabling illness or injury, return to work more often and spend less time away from work on leave than those without the integrated program. This is the conclusion of a new study by CIGNA comparing integrated and non-integrated disability and medical plans.

25 Feb 2011

Neoprobe's Lymphoseek Phase 2 study data published in Annals of Surgical Oncology

Neoprobe Corporation (NEOP), a diversified developer of innovative oncology surgical and diagnostic products, today announced that results from a Phase II study of Lymphoseek® (Tilmanocept) have been published online in the Annals of Surgical Oncology and demonstrate the tracing agent's ability to identify tumor-draining lymph nodes in breast cancer and melanoma patients.

25 Feb 2011

Hospitals and health system innovations designed to increase efficiency, improve outcomes

News outlets report on how certain health care models are performing in these difficult economic times.

25 Feb 2011

HHS offers new grants to help states with insurance rate reviews

These grants are designed to assist states in creating or enhancing their reviews of the premiums charged by health insurance companies.

25 Feb 2011

Research News and Research

Scripps Health offers genetic testing to patients with Hepatitis C

Acute viral infection does not appear to cause exacerbation of IPF

Researchers identify gene behind self-healing skin cancer

Johns Hopkins students to provide hands-on help to communities in need on spring break trip

Scientists discover killer protein that protects against development of cancer

New findings disclose mechanisms that control Rb2/p130 gene expression in lung cancer cells

Encouraging preliminary results from Synta's ganetespib Phase 2 trial against non-small cell lung cancer

Takeda receives FDA approval for EDARBI to treat hypertension in adults

New study: Immune molecules can regulate synaptic connections in brain

Lyme’s disease and chronic fatigue syndrome biomarkers found

Well-being in adolescence linked to life satisfaction in adulthood

Less-toxic combination of immune-based drug and chemotherapy drug produce long-term remissions in CLL

Research Roundup: Health costs at life's end; Assessing hospital quality; Surgeons' burnout; Per capita Medicaid spending

State News: Ga. Senate oks insurance mandates bill; Va. Assembly says abortion clinics should be regulated as hospitals

Viewpoints: WSJ on Medicare Advantage, Texas Gov. Perry on 'Fed inroads,' Med students' health policy ignorance

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

CIGNA's integrated disability and medical programs reduce workplace absence

Neoprobe's Lymphoseek Phase 2 study data published in Annals of Surgical Oncology

Hospitals and health system innovations designed to increase efficiency, improve outcomes

HHS offers new grants to help states with insurance rate reviews

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News